Therapy Areas: Diabetes
Genprex enters into exclusive patent license agreement with NYU Langone Health to advance mesothelioma gene therapy
28 April 2025 - Gene therapy company Genprex Inc (NASDAQ: GNPX) announced on Monday that it has signed an exclusive patent license agreement with NYU Langone Health for the development of Reqorsa®...
Diamyd Medical to receive European patent for insulin antigen treatment targeting autoimmune diabetes
28 April 2025 - Swedish biotechnology company Diamyd Medical AB (Nasdaq First North Growth Market:DMYD-B) announced on Monday that the European Patent Office (EPO) has said it will grant Diamyd Medica...
Renalytix reports real-world impact of KidneyIntelX on targeted kidney disease treatment
16 April 2025 - Precision medicine company Renalytix plc (LSE: RENX, OTCQB: RNLXY) on Wednesday announced new clinical data demonstrating the positive impact of its KidneyIntelX test on prescribing pa...
Aditxt reports positive preclinical results from Mayo Clinic study supporting ADI-100 for autoimmune diseases
14 April 2025 - Aditxt Inc (NASDAQ: ADTX) reported on Monday that its wholly owned subsidiary Adimune Inc announced positive results from preclinical studies conducted by the Mayo Clinic, supporting t...
Poxel secures new patent in Japan for Imeglimin use in type 2 diabetic patients with renal impairment
31 March 2025 - Clinical stage biopharmaceutical company Poxel SA (Euronext Paris:POXEL) announced on Monday that the Japanese Patent Office has granted a new patent (number 7635474) covering the use ...
Langhua Pharmaceutical passes US FDA's on-site inspection
31 March 2025 - Viva Biotech Holdings announced on Friday that its wholly-owned subsidiary, Zhejiang Langhua Pharmaceutical Co., Ltd., successfully completed a cGMP on-site inspection by the US Food a...